Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Flutter Entertainment
FLUT
|
+$760M |
| 2 |
Microsoft
MSFT
|
+$501M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$437M |
| 4 |
NVIDIA
NVDA
|
+$421M |
| 5 |
Intel
INTC
|
+$329M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Compañía de Minas Buenaventura
BVN
|
+$314M |
| 2 |
CVS Health
CVS
|
+$158M |
| 3 |
Uber
UBER
|
+$133M |
| 4 |
First Trust NASDAQ Cybersecurity ETF
CIBR
|
+$123M |
| 5 |
Invesco KBW Bank ETF
KBWB
|
+$114M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.48% |
| 2 | Healthcare | 6.01% |
| 3 | Consumer Discretionary | 5.84% |
| 4 | Financials | 5.09% |
| 5 | Communication Services | 3.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3901
iRadimed
IRMD
$1.2B
| $188K | ﹤0.01% |
4,265
+3,200
| +300% | +$141K |
|
|
REFI
3902
Chicago Atlantic Real Estate Finance
REFI
$251M
| $186K | ﹤0.01% |
11,814
+8,471
| +253% | +$136K |
|
|
WW
3903
CALL
DELISTED
WW International
WW
| $185K | ﹤0.01% |
+100,000
| New | +$398K |
|
3904
iShares Russell 2500 ETF
SMMD
$3.53B
| $185K | ﹤0.01% |
2,819
+470
| +20% | +$29.1K |
|
3905
Genco Shipping & Trading
GNK
$1.1B
| $184K | ﹤0.01% |
9,068
+2,279
| +34% | +$42.2K |
|
3906
VistaGen Therapeutics
VTGN
$9.98M
| $184K | ﹤0.01% |
34,906
-23,471
| -40% | -$113K |
|
3907
Stratasys
SSYS
$666M
| $184K | ﹤0.01% |
15,859
-26,151
| -62% | -$336K |
|
3908
VanEck Preferred Securities ex Financials ETF
PFXF
$2.37B
| $183K | ﹤0.01% |
10,354
-1,135
| -10% | -$19.9K |
|
3909
Vanguard Mega Cap Value ETF
MGV
$13.1B
| $182K | ﹤0.01% |
1,525
+35
| +2% | +$3.96K |
|
|
BRSP
3910
BrightSpire Capital
BRSP
$651M
| $182K | ﹤0.01% |
26,443
+5,874
| +29% | +$41K |
|
3911
PubMatic
PUBM
$608M
| $182K | ﹤0.01% |
7,652
+1,614
| +27% | +$28.9K |
|
3912
E.W. Scripps
SSP
$270M
| $181K | ﹤0.01% |
46,177
+4,931
| +12% | +$29.5K |
|
3913
Evolus
EOLS
$397M
| $180K | ﹤0.01% |
12,878
-1,080
| -8% | -$14K |
|
|
SYRS
3914
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $180K | ﹤0.01% |
+33,624
| New | +$233K |
|
3915
Dole
DOLE
$1.38B
| $178K | ﹤0.01% |
14,949
+3,123
| +26% | +$36.2K |
|
3916
BlackRock Corporate High Yield Fund
HYT
$1.35B
| $178K | ﹤0.01% |
18,188
+2,548
| +16% | +$24.6K |
|
3917
Sera Prognostics
SERA
$80.3M
| $178K | ﹤0.01% |
19,536
-49,813
| -72% | -$395K |
|
3918
JPMorgan BetaBuilders Europe ETF
BBEU
$9.17B
| $178K | ﹤0.01% |
+2,991
| New | +$171K |
|
3919
Spok Holdings
SPOK
$229M
| $177K | ﹤0.01% |
11,113
+1,083
| +11% | +$17.8K |
|
3920
X4 Pharmaceuticals
XFOR
$377M
| $177K | ﹤0.01% |
4,235
+3,647
| +620% | +$101K |
|
|
PHX
3921
DELISTED
PHX Minerals
PHX
| $176K | ﹤0.01% |
51,704
-32,962
| -39% | -$103K |
|
3922
Metagenomi Therapeutics
MGX
$45.6M
| $176K | ﹤0.01% |
+16,668
| New | +$192K |
|
3923
First Trust US Equity Opportunities ETF
FPX
$1.43B
| $175K | ﹤0.01% |
1,657
-157
| -9% | -$15.5K |
|
3924
Union Bankshares
UNB
$109M
| $175K | ﹤0.01% |
5,739
-542
| -9% | -$16.5K |
|
3925
IDT Corp
IDT
$1.67B
| $174K | ﹤0.01% |
4,609
+439
| +11% | +$15.7K |
|
Similar funds
Citigroup's Q1 2024 Portfolio in Review
As of Q1 2024, Citigroup held 5,965 positions worth $152B, up 7.3% from $142B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Citigroup's Q1 2024 filing shows 313 new, 3,053 increased, 1,591 reduced and 350 closed positions. Its largest new stake was Flutter Entertainment: 3,560,398 shares worth $7.03M. The largest sale was Compañía de Minas Buenaventura, an estimated $314M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Citigroup's largest Q1 2024 buy was Flutter Entertainment: 3,560,398 shares worth $7.03M.
- Citigroup added most to Microsoft in Q1 2024, an estimated $501M increase.
- Citigroup's biggest Q1 2024 reduction was Compañía de Minas Buenaventura, cutting an estimated $314M.
- Citigroup fully exited Splunk Inc in Q1 2024, selling an estimated $86.3M.
- Citigroup's ten largest holdings make up 24% of its $152B portfolio in Q1 2024.
- Citigroup opened 313 new positions and closed 350 in Q1 2024.
- Citigroup's portfolio value rose 7.3% quarter-over-quarter to $152B.
Based on Citigroup's 13F filing for Q1 2024, filed 10 May 2024.